Clinical Trial Update: Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase II study evaluating the combination of docetaxel and gefitinib (ZD1839) in elderly patients with non-small cell lung cancer; results of the trial have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Gefitinib (Gefitinib)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-11-30